製藥、生技、臨床診斷、醫療服務與健康照護產業的市場研究與管線分析。目前收錄 1,886 份相關報告。
Key data points: The market size in 2035 = $607 billion, growth forecast = 2.9% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in medical d
Key data points: The market size in 2035 = $640 million, growth forecast = 3.9% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in patient t
Key data points: The market size in 2035 = $198 million, growth forecast = 4.8% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in chiral ch
Key data points: The market size in 2035 = $396 billion, growth forecast = 6.9% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in pharmaceu
Key data points: The market size in 2035 = $2,062 billion, growth forecast = 13.3% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in health
Key data points: The market size in 2035 = $1,125 million, growth forecast = 16.1% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in exosom
Key data points: The market size in 2035 = $149 billion, growth forecast = 6.5% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in diabetes
Key data points: The market size in 2035 = $145 billion, growth forecast = 7.5% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in portable
Anthracycline APIs are cytotoxic antineoplastic active pharmaceutical ingredients in the WHO ATC L01DB anthracycline class, used as the drug-substance basis for sterile oncology products. In commercial API terms, the cat
Hemocompatible coatings constitute advanced interfacial modifications applied to the surfaces of blood-contacting medical devices to mitigate the risk of thrombosis and associated complications. These coatings function b
Drug-delivery coatings for medical devices represent a specialized class of functionalized biomaterials engineered to serve as localized reservoirs for the controlled release of therapeutic agents directly at the site of
Polymeric coatings for drug delivery are drug-containing polymer layers engineered on a product surface to store an active pharmaceutical ingredient and govern its release to the surrounding tissue or fluid environment o